Background: Existing clinical decision rules (CDRs) to diagnose group A streptococcal (GAS) pharyngitis have not been validated in sub-Saharan Africa. We developed a locally applicable CDR while evaluating existing CDRs for diagnosing GAS pharyngitis in South African children. Methods: We conducted a prospective cohort study and enrolled 997 children 3-15 years of age presenting to primary care clinics with a complaint of sore throat, and whose parents provided consent. Main outcome measures were signs and symptoms of pharyngitis and a positive GAS culture from a throat swab. Bivariate and multivariate analyses were used to develop the CDR. In addition, the diagnostic effectiveness of 6 existing rules for predicting a positive culture in our cohort was assessed. Results: A total of 206 of 982 children (21%) had a positive GAS culture. Tonsillar swelling, tonsillar exudates, tender or enlarged anterior cervical lymph nodes, absence of cough and absence of rhinorrhea were associated with positive cultures in bivariate and multivariate analyses. Four variables (tonsillar swelling and one of tonsillar exudate, no rhinorrhea, no cough), when used in a cumulative score, showed 83.7% sensitivity and 32.2% specificity for GAS pharyngitis. Of existing rules tested, the rule by McIsaac et al had the highest positive predictive value (28%), but missed 49% of the culture-positive children who should have been treated.
A ntibiotic treatment of pharyngitis with clinical features suggestive of a group A β-hemolytic streptococcus (GAS) etiology reduces the incidence of acute rheumatic fever (ARF) by 68%. 1 The primary prevention of ARF with antibiotics represents an important strategy for reducing the burden of rheumatic heart disease (RHD), 2 which accounts for 14% of cases of acute heart failure in sub-Saharan Africa. 3 The diagnosis of GAS pharyngitis can be made directly by microbiologic culture, 4 or indirectly based on rapid streptococcal assays, 5 or through the use of a clinical decision rule. 6 Clinical decision rules are practical decision tools to aid diagnostic evaluation, particularly in low-resourced settings where laboratory facilities may not be available. Clinical decision rules incorporate a limited number of clinical characteristics, to derive a probability score for directing a course of action. 7, 8 We have recently demonstrated that the use of a clinical decision rule is the most cost-effective strategy for the primary prevention of ARF in South African children with sore throat. 9 Existing clinical decision rules to diagnose GAS pharyngitis have not been validated in some regions of the world, such as sub-Saharan Africa, where RHD is endemic. An Egyptian study showed that the diagnostic performance varies considerably in different communities and regions of the world, 10 thus highlighting the importance of evaluating and validating clinical decision rules in local settings before they are rolled out as the standard of care. 11 We developed a locally applicable clinical decision rule for streptococcal pharyngitis in children with sore throat from Cape Town. In addition, we evaluated the performance of existing clinical decision rules for diagnosing streptococcal pharyngitis in South African children.
MATERIALS AND METHODS

Study Site, Recruitment and Diagnosis of GAS Pharyngitis
This study was conducted from May 2008 to October 2013. We recruited children 3-15 years of age who presented with sore throat to 3 community clinics in Langa and Bonteheuwel, Cape Town and South Africa. Participants who had received a prescription of antibiotics, the last dose of which was taken within 30 days of enrolment, were excluded. Informed consent was obtained from the parent or legal guardian. Assent was also obtained from children ≥8 years of age. A medical history was taken, and clinical examination of the child was performed by the trained study nurse. A throat swab was obtained as follows: a sterile cotton swab was slowly applied across 1 tonsil or tonsillar fossa, then across the posterior pharynx, and finally across the opposite tonsil or tonsillar fossa, without touching the tongue or mouth. Swabs with liquid media tips were used. Swabs were then returned to their sheaths, which contain a transport medium at the tip for the swab.
Throat swabs were transported in an insulated bag to the National Health Laboratory Service microbiology laboratory at Groote Schuur Hospital in Cape Town for incubation. Specimens received as appropriately labeled swabs were plated onto 4% sheep blood agar plates in a standard fashion. Every effort was made to place specimens in an incubator no later than 4 hours from the time of collection. Plates were inverted and incubated anaerobically at 35°C. After 18-24 hours, the plates were examined by the microbiology technician, under the supervision of one of us (A.C.W.). Laboratory-confirmed GAS culture positivity was the reference standard for the diagnosis of GAS pharyngitis. Further confirmation was done through Gram stain, catalase and serogrouping, as appropriate. A single colony was picked off with a sterile wire loop and subcultured for purity. Culture results from the study were returned to the clinic for filing in the patient's medical record.
Measurement of Potential Predictor Variables
The selection of potential predictor variables was based on the clinical decision rules that performed best in an Egyptian prospective study (sensitivity and specificity of more than 90% and 30%, respectively). 6 Together with age, sex, race and place of residence, we recorded presence or absence of the following signs and symptoms: cough, rhinorrhea, hoarseness, fever (>38°C), tonsillar erythema or swelling, pharyngeal or tonsillar exudate, tenderness of an anterior cervical lymph node on palpation, an anterior cervical lymph node >1.5 cm in diameter (ie, swelling) and rash. In addition, the presence or absence of oropharyngeal candidiasis was recorded, in view of the high prevalence of HIV infection in South Africa.
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Sample Size
For derivation of the clinical decision rule, we required 10 events per candidate predictor. 13 The expected prevalence of GAS in children with pharyngitis was 30%. 14, 15 Our initial estimate was that we would need to recruit 450 participants to obtain 150 GAS cases for the 15 candidate predictors (including age and sex). Preliminary analysis indicated a lower than expected prevalence of GAS (16%) in our study cohort. We therefore revised our target sample size to 940 participants.
Statistical Analysis
Statistical analysis was performed using Stata (version 11.2; StataCorp, College Station, TX), SAS/STAT v.9.1 (SAS Institute Inc., Cary, NC) and R version 3.0.0 (2013-04-03) (The R Foundation for statistical computing, Vienna, Austria). Proportions or means were calculated to describe the baseline characteristics of the study population. We generated scores according to the criteria contained in the existing rules to estimate the probability of a GASpositive culture. We aimed to develop a clinical decision rule with a sensitivity of ≥90% and specificity of ≥40%.
We calculated univariable odds ratios with 95% confidence intervals (CIs) to examine the relationship between each individual predictor with the primary outcome measure, that is, a laboratoryconfirmed GAS culture from the throat swab specimen. For continuous predictors, the functional form of the association with the outcome was checked using restricted cubic splines, to find the proper transformation if needed. 16 Variables were then selected for inclusion in the final logistic regression model following the stepwise approach proposed by Collett. 17 The following interactions were tested in the final model: cough, rhinorrhoea, tonsillar swelling and tonsillar exudate.
Calibration was assessed graphically through calibration plots and by computing the Hosmer and Lemeshow (HL) test. Discrimination was assessed by estimating the C-statistic. C-statistics vary from 0.5 (no discrimination) to 1 (perfect discrimination), with values of 0.7-0.8 deemed acceptable and 0.8-0.9 good. 18 Internal validation of the model used 2000 bootstrap resamples. 16 To promote the uptake in routine settings, the new clinical decision rule was constructed incorporating previously described methods, [19] [20] [21] where the logistic formula was transformed into a ready to use score chart. Beta coefficients were divided by a constant; predictors with a negative association were inverted and evaluated as positive entities; the total score was then compared with the observed proportion of GAS positivity in our cohort. Thereafter, receiveroperating characteristic curves were used to derive the optimal threshold point score by applying the index approach by Youden. 22 We evaluated the diagnostic effectiveness of previously developed clinical decision rules (included in the Egyptian study) as well as additional clinical decision rules identified in a recent systematic review, against our data. 23 We determined performance only for those clinical decision rules for which we had data on all predictors included in the clinical decision rule: the rules by Abu Reesh, 24 Wald et al, 25 World Health Organization, 26 Steinhoff et al, 6 McIsaac et al 20 and Attia et al. 27 We determined sensitivity, specificity, positive and negative predictive value, positive likelihood ratios, diagnostic odds ratio, area under the receiver-operating curve and statistic for each rule by Youden 22 at the cut point/range of cut points suggested by the authors. Performance of the derived clinical decision rule was compared using the ratio of missed streptococcal cases [missed diagnoses (MDx)] against unnecessarily treated noncases [wrong diagnoses (WDx)]. 6 We defined a successful clinical decision rule as 1 with a sensitivity of ≥90% and a specificity of ≥40%, which corresponds to a MDx-to-WDx ratio of 0.044 in our cohort. Data were stored using Epi-Info software (version 3.5.3, CDC, Atlanta, GA), and double entry verification was adopted to reduce data entry error.
Ethics Approval
The study was approved by the University of Cape Town's institutional review board and the department of health of the Western Cape. The consent forms were provided in the local languages of Afrikaans, English and isiXhosa.
RESULTS
During the study period, 1055 children with sore throat presented to the participating community clinics. Of these, informed consent was obtained for 997 participants, of whom 993 met the inclusion criteria and were recruited into the study. Reasons for the 4 exclusions were antibiotic treatment in the preceding 30 days (n = 2), age greater than 15 years (n = 1) and refusal by the child to allow a throat swab to be taken (n = 1). GAS laboratory results were available for 982 children.
The demographic characteristics of the 982 children included in the analysis are presented in Table 1 . A laboratory-confirmed diagnosis of GAS was reported in 206 (21%) children, which was higher than the proportion of 16% found at preliminary analysis. Table 2 shows the results of the association between throat culture results and individual variables. Tonsillar swelling was the univariable predictor most strongly associated with a positive GAS culture P value <001. Five variables were significant predictors of GAS positivity: tonsillar swelling (P < 0.001), a temperature >38°C (P = 0.002), presence of exudate on the tonsils (P < 0.001), tenderness of an anterior cervical node on palpation (P = 0.002) and the presence of an anterior cervical lymph node >1.5 cm in diameter (P = 0.028). Significant negative predictors of GAS positivity were the presence of cough (P < 0.001) and rhinorrhoea (P = 0.002). The calibration curve from the final model (Fig. 1A) followed the ideal calibration line, indicating a near-perfect agreement between the rate of streptococcal pharyngitis estimated by the model and the streptococcal pharyngitis frequency observed in the study population. This near-perfect agreement was confirmed by the HL test: Hl-χ 2 = 1.30 (P = 0.99). The model's discriminatory performance as demonstrated in a plotting of sensitivity versus 1 − specificity (receiver-operating characteristic curve) was quantified by the area under the curve, C-statistic = 0.638 (95% CI: 0.597-0.678) (Fig. 1B) . The equivalents in bootstrap validation were 0.633 (95% CI: 0.625-0.641); the optimism estimate was 0.0086 (95% CI: −0.0304 to 0.0476; P = 0.666), indicating good stability of the model in bootstrap internal validation. Table 3 illustrates the scoring system of the Cape Town clinical decision rule developed to calculate the risk of GAS positivity in an individual participant. Clinical predictors were converted into points allocated for each predictor value and summed into a total score of 5. Table 4 depicts the performance of the Cape Town clinical decision rule for GAS pharyngitis for scores ranging from 1 to 5 out of a total of 5. A score of 3.5 had the most discriminatory ability with a sensitivity of 51.2%, specificity of 68.2%, positive predictive value of 30.1% and negative predictive value of 83.9%. A score of 3 against existing clinical decision rules in our cohort is provided in Table 5 . The Cape Town rule proved to have an MDx-to-WDx ratio closest to 0.044, which met our target parameters of a sensitivity of ≥90% and a specificity of ≥40%.
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DISCUSSION
We developed a new clinical decision rule for streptococcal pharyngitis in children from Cape Town (the Cape Town clinical decision rule) by incorporating the presence of tonsillar exudate and swelling, and absence of both cough and rhinorrhoea to determine the likelihood of GAS positivity in children with pharyngitis. The Cape Town clinical decision rule has a maximum score of 5 points with 2 points allocated to the presence of tonsillar swelling and 1 point each for the remaining variables. It has a sensitivity of MDx (%) indicates number of missed diagnoses of streptococcal pharyngitis and percentage of all true streptococcal cases (= 1 − sensitivity); WDx (%) indicates number of wrong diagnoses (unnecessarily treated noncases) and percentage of all nonstreptococcal cases (= 1 − specificity). *Evaluated at the suggested score of 3/5 incorporating tonsillar swelling as compulsory symptom. LR+ indicates positive likelihood ratio; NPV, negative predictive value all expressed as percentages; PPV, positive predictor value; Sens, sensitivity; Spec, specificity.
